Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2021 September;63(3) > Panminerva Medica 2021 September;63(3):382-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Panminerva Medica 2021 September;63(3):382-3

DOI: 10.23736/S0031-0808.19.03685-1

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

MAGEA3 serves as an independent indicator for predicting the prognosis of ESCC

Shenxiang LIU 1, 2, Hongyan CHEN 3, Xiaolin GE 1, Zhenzhen GAO 4, Yu SHI 1, Min YANG 1, 5

1 Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 2 Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China; 3 Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 4 Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 5 Molecular Imaging Center, Jiangsu Institute of Atomic Medicine, Wuxi, China



top of page